AEPCX
Price
$59.33
Change
-$0.17 (-0.29%)
Updated
Aug 14 closing price
Net Assets
135.65B
MXIGX
Price
$14.25
Change
-$0.05 (-0.35%)
Updated
Aug 14 closing price
Net Assets
599.96M
Interact to see
Advertisement

AEPCX vs MXIGX

Header iconAEPCX vs MXIGX Comparison
Open Charts AEPCX vs MXIGXBanner chart's image
American Funds EUPAC C
Price$59.33
Change-$0.17 (-0.29%)
VolumeN/A
Net Assets135.65B
Empower International Growth I
Price$14.25
Change-$0.05 (-0.35%)
VolumeN/A
Net Assets599.96M
AEPCX vs MXIGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. MXIGX commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and MXIGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 136B vs. MXIGX (600M). MXIGX pays higher dividends than AEPCX: MXIGX (1.08) vs AEPCX (0.17). AEPCX was incepted earlier than MXIGX: AEPCX (24 years) vs MXIGX (22 years). AEPCX (1.57) is less costly to investors than MXIGX (1.37). MXIGX is a more actively managed with annual turnover of: 42.00 vs. AEPCX (35.00). MXIGX has a lower initial minimum investment than AEPCX: MXIGX (0) vs AEPCX (250). AEPCX annual gain was more profitable for investors over the last year : 8.15 vs. MXIGX (6.10). AEPCX return over 5 years is better than : 8.18 vs. MXIGX (2.55).
AEPCXMXIGXAEPCX / MXIGX
Total Expense Ratio1.571.20131%
Annual Report Gross Expense Ratio1.571.37115%
Fund Existence24 years22 years-
Gain YTD14.82510.767138%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets136B600M22,667%
Annual Yield % from dividends0.171.0816%
Returns for 1 year8.156.10134%
Returns for 3 years20.7721.2298%
Returns for 5 years8.182.55321%
Returns for 10 years25.6022.96111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PYXS1.130.06
+5.61%
Pyxis Oncology
QGEN48.96-0.27
-0.55%
Qiagen N.V.
FIVN25.14-1.06
-4.05%
Five9
SBC4.06-0.26
-5.91%
SBC Medical Group Holdings Incorporated
SMTK0.60-0.09
-13.04%
SmartKem Inc.